SciClone to Report Fourth Quarter and Year-End 2005 Results on March 1, 2006
Posted on: Wednesday, 8 February 2006, 06:00 CST
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that it plans to report fourth quarter and year-end 2005 results and host a conference call on Wednesday, March 1, 2006.
The conference call will contain forward-looking statements. Financial and statistical information to be discussed on the call will be posted on the Investor Relations section of SciClone's web site at www.sciclone.com prior to the commencement of the conference call.
DATE: Wednesday, March 1, 2006 TIME: 11:30 a.m. ET (8:30 a.m. PT) WEBCAST: live call and replay accessible at www.sciclone.com LIVE CALL: 877-502-9276 (U.S./Canada) 913-981-5591 (international) REPLAY: 888-203-1112 (U.S./Canada) 719-457-0820 (international) passcode: 4478213
About SciClone
SciClone Pharmaceuticals is a biopharmaceutical company engaged in the development of therapeutics to treat life-threatening diseases. SciClone's lead product ZADAXIN(R) is currently being evaluated in late-stage clinical trials for the treatment of malignant melanoma and hepatitis C. ZADAXIN is approved for sale in select markets internationally, most notably in China where SciClone has an established sales and marketing operation. SciClone's strategy is to leverage its advantage in China by in-licensing or acquiring the marketing rights to other products to market in this rapidly growing pharmaceutical market. SciClone's other drug development candidate is SCV-07, currently in early clinical development in the U.S. for the treatment of viral and other infectious diseases. For more information about SciClone, visit www.sciclone.com.
Corporate information contact: Becky Horner Investor Relations SciClone Pharmaceuticals, Inc. 650-358-3437
SOURCE: SciClone Pharmaceuticals, Inc.
Source: MARKET WIRE
Related Articles
- Call for Submissions Now Open for the 2010 Game Developers Conference(R) Canada
- 2010 Game Developers Conference Opens Call for Submissions Now Through August 14
- Think Services' 2009 Game Developers Conference China Opens Call for Submissions
- Call for Submissions Now Open for the 2009 Game Developers Conference Austin
- 2009 Game Developers Conference(R) Europe Opens Call For Submissions
- The 2nd China Game Developers Conference Calls for Papers
- TMC Announces Call for Papers for 2008 Communications Developer Conference in Los Angeles
- NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the GTCbio Cancer Drugs Research & Development Conference
- Novavax Head of Pharmaceutical Development to Present on Micellar Nanoparticle Technology at Particles 2006 Meeting
- Leading Healthcare Executives, Private Equity Funds and Dealmakers Convene at 2006 Healthcare M&A & Corporate Development Conference in Chicago This May
 |
 |
User Comments (0)
RSS Feeds